Irinotecan hydrochloride injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Irinotecan hydrochloride injection, covering 2025-07-29 to 2025-07-29. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized Controlled Study Comparing the Safety and Efficacy of Irinotecan Hydrochloride Liposome Injection Combined With Temozolomide and Vincristine (NALIRI-VT) Versus Irinotecan Combined With Temozolomide and Vincristine (VIT) in Patients With Advanced Ewing's Sarcoma [Phase 2]